ATE453380T1 - Verabreichung von in lipidvesikeln verpackten kleinen hydrophilen molekülen - Google Patents

Verabreichung von in lipidvesikeln verpackten kleinen hydrophilen molekülen

Info

Publication number
ATE453380T1
ATE453380T1 AT02743969T AT02743969T ATE453380T1 AT E453380 T1 ATE453380 T1 AT E453380T1 AT 02743969 T AT02743969 T AT 02743969T AT 02743969 T AT02743969 T AT 02743969T AT E453380 T1 ATE453380 T1 AT E453380T1
Authority
AT
Austria
Prior art keywords
administration
lipid vesicles
hydrophilic molecules
small hydrophilic
molecules packaged
Prior art date
Application number
AT02743969T
Other languages
English (en)
Inventor
Robert Friesen
Berend Poolman
Bernard Lucas Feringa
Jan Engberts
Original Assignee
Applied Nanosystems Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Nanosystems Bv filed Critical Applied Nanosystems Bv
Application granted granted Critical
Publication of ATE453380T1 publication Critical patent/ATE453380T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02743969T 2001-06-21 2002-06-21 Verabreichung von in lipidvesikeln verpackten kleinen hydrophilen molekülen ATE453380T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01202401A EP1269993A1 (de) 2001-06-21 2001-06-21 Verabreichung von in Lipidvesikeln verpackten kleinen hydrophilen Molekülen
PCT/NL2002/000412 WO2003000233A2 (en) 2001-06-21 2002-06-21 Delivery of small hydrophilic molecules packaged into lipid vesicles

Publications (1)

Publication Number Publication Date
ATE453380T1 true ATE453380T1 (de) 2010-01-15

Family

ID=8180516

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02743969T ATE453380T1 (de) 2001-06-21 2002-06-21 Verabreichung von in lipidvesikeln verpackten kleinen hydrophilen molekülen

Country Status (7)

Country Link
US (1) US20030118636A1 (de)
EP (2) EP1269993A1 (de)
AT (1) ATE453380T1 (de)
CA (1) CA2451148A1 (de)
DE (1) DE60234921D1 (de)
DK (1) DK1397123T3 (de)
WO (1) WO2003000233A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8815577B2 (en) 2001-07-30 2014-08-26 Meso Scale Technologies, Llc Assay electrode having immobilized lipid/protein layers, methods of making the same and methods of using the same for luminescence test measurements
WO2003075889A1 (en) * 2002-03-05 2003-09-18 Transave, Inc. An inhalation system for prevention and treatment of intracellular infections
US7718189B2 (en) * 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
KR101301653B1 (ko) * 2002-10-29 2013-08-30 트랜세이브, 인코포레이티드 항감염제의 지속적인 방출
US7968115B2 (en) 2004-03-05 2011-06-28 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of cancer
US7459147B2 (en) 2003-06-30 2008-12-02 L'oreal Cosmetic composition comprising at least one hydrophilic organopolysiloxane, at least one hydrocarbon oil and at least one short hydrocarbon ester
US20080103213A1 (en) * 2004-03-05 2008-05-01 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of neurofibromatosis
US8784881B2 (en) 2004-03-05 2014-07-22 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of diseases
JP5324223B2 (ja) 2005-12-08 2013-10-23 トランセイブ， インク． 肺感染症を治療する抗感染薬の脂質ベースの組成物及びその使用法
US20100196455A1 (en) * 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US20100189777A1 (en) * 2007-07-20 2010-07-29 Basf Se Functionalized nanocompartments with a transport system
EP2127640A1 (de) 2008-05-27 2009-12-02 Koninklijke Philips Electronics N.V. Modifizierte azid-enthaltende Proteine
RU2531639C2 (ru) 2009-06-24 2014-10-27 Конинклейке Филипс Электроникс Н.В. Способ и устройство для программирования микроконтроллера
WO2011097480A1 (en) * 2010-02-05 2011-08-11 University Of Louisville Research Foundation, Inc. Exosomal compositions and methods for the treatment of disease
PL2852391T3 (pl) 2012-05-21 2022-04-11 Insmed Incorporated Układy do leczenia infekcji płuc
WO2014081300A1 (en) * 2012-11-22 2014-05-30 Tagworks Pharmaceuticals B.V. Channel protein activatable liposomes
MX2015006681A (es) 2012-11-29 2016-04-06 Insmed Inc Formulaciones de vancomicina estabilizadas.
EP2968149B1 (de) * 2013-03-14 2024-05-08 Dicerna Pharmaceuticals, Inc. Verfahren zur herstellung eines anionischen mittels
SMT202000516T1 (it) 2014-05-15 2020-11-10 Insmed Inc Metodi per trattamento di infezioni micobatteriche polmonati non tubercolari
WO2019191627A1 (en) 2018-03-30 2019-10-03 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
WO2019213398A1 (en) 2018-05-02 2019-11-07 Insmed Incorporated Methods for the manufacture of liposomal drug formulations

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4900556A (en) * 1985-04-26 1990-02-13 Massachusetts Institute Of Technology System for delayed and pulsed release of biologically active substances
US5252263A (en) * 1986-06-16 1993-10-12 The Liposome Company, Inc. Induction of asymmetry in vesicles
CA1335879C (en) * 1987-07-27 1995-06-13 Bruce Andrew Cornell Receptor membranes
US5227470A (en) * 1988-08-26 1993-07-13 Canon Kabushiki Kaisha Method for forming proteoliposome and method for forming giant proteoliposome
US5874316A (en) * 1989-01-27 1999-02-23 Australian Membrane Biotechnology Research Institute Receptor membranes and ionophore gating
ATE153673T1 (de) * 1989-01-27 1997-06-15 Au Membrane & Biotech Res Inst Rezeptormembranen und selektive steuerung des ionenflusses durch ionophoren
US5753258A (en) * 1990-10-19 1998-05-19 University Of Florida Artificial viral envelopes
US5252348A (en) * 1990-10-19 1993-10-12 Univ. Of Florida Research Foundation, Inc. Artificial viral envelopes
US5820879A (en) * 1993-02-12 1998-10-13 Access Pharmaceuticals, Inc. Method of delivering a lipid-coated condensed-phase microparticle composition
US5753261A (en) * 1993-02-12 1998-05-19 Access Pharmaceuticals, Inc. Lipid-coated condensed-phase microparticle composition
DK0712935T3 (da) * 1994-11-18 2002-07-15 Stichting Nl I Voor Zuivelonde Fremgangsmåde til styring af genekspressionen i mælkesyrebakterier
WO1999003889A1 (en) * 1997-07-15 1999-01-28 The Regents Of The University Of California Isolated dna encoding human calcium activated potassium channel
US6165732A (en) * 1997-10-14 2000-12-26 Washington University Method for identifying apoptosis modulating compounds
GB9721901D0 (en) * 1997-10-16 1997-12-17 Univ Manchester Particles

Also Published As

Publication number Publication date
EP1397123A2 (de) 2004-03-17
EP1269993A1 (de) 2003-01-02
DK1397123T3 (da) 2010-05-03
CA2451148A1 (en) 2003-01-03
EP1397123B1 (de) 2009-12-30
US20030118636A1 (en) 2003-06-26
WO2003000233A2 (en) 2003-01-03
DE60234921D1 (de) 2010-02-11
WO2003000233A3 (en) 2003-10-16

Similar Documents

Publication Publication Date Title
DE60234921D1 (de) Verabreichung von in lipidvesikeln verpackten kleinen hydrophilen molekülen
DK1019025T3 (da) Peptid/lipid-kompleksdannelse ved co-frysetørring
ATE263579T1 (de) Abgabe von polyethylene glycol-molekül- konjugaten aus abbaubarem hydrogel
ATE322255T1 (de) Polyamid-oligomere
ATE368054T1 (de) Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität
DK0909183T3 (da) DHA-konjugerede farmaceutisk midler
DK0783297T3 (da) Polyethylenglycol-modificerede ceramid-lipider og liposomer
ID27788A (id) Peptida-peptida antigen tumor yang diperoleh dari siklofilin b
EP1490483A4 (de) In-vivo-einbau von nicht in der natur vorkommenden aminosäuren
NO993257D0 (no) N-acylfosfatidyletanolaminformidlet liposomal legemiddelavlevering
ATE244015T1 (de) Formulierungen fuer faktor ix
TR200400295T2 (tr) Kimyasal olarak modifiye edilmiş ensülin'in akçiğer yoluyla verilmesi
CY1105690T1 (el) Μεθοδοι και σκευασματα για χορηγηση ταξανιων
TR199903331T2 (xx) Farnesil protein transferas engelleyicileri.
CY1105953T1 (el) Συνθεσεις για απελευθερωση συνδυασμων φαρμακων
ES2216055T3 (es) Metodos para reducir o mantener niveles reducidos de lipidos en sangre usando composiciones de proteina ob.
CY1106886T1 (el) Πολυμερη προϊοντα συζευξης της neublastin και μεθοδοι χρησης αυτων
CY1120831T1 (el) Μεθοδοι μειωσης της συσσωματωσης toy il-1ra
DE60126760D1 (de) Vektorkonstrukte
ATE252888T1 (de) Lipid haltige zusammenstellungen und deren verwendungen
ATE455561T1 (de) Konjugate von zytotoxischen mitteln und biologisch aktiven peptiden
ATE373466T1 (de) Lipidträgerzusammensetzungen und verfahren zur verbesserten wirkstoffzurückhaltung
ATE301709T1 (de) Lipidabkömmlinge von pentaerythritol
BR0207654A (pt) Composição que compreende um creme ou loção base
PT1135193E (pt) Agentes para o tratamento de tumores a base de lipossomas e compreendendo tamoxifeno

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties